Applications of (S)-3-Aminopiperidine Dihydrochloride in Industrial Manufacturing

(S)-3-Aminopiperidine Dihydrochloride serves as a key intermediate for advanced synthesis in pharmaceutical, agrochemical, and specialty chemical production. As an original chemical manufacturer, we provide consistently pure material suitable for compliance-driven applications where precise chirality and batch traceability are essential for downstream product performance, regulatory filing, and process safety.

1. Active Pharmaceutical Ingredient (API) Synthesis: Antiviral Drug Intermediates

Pharmaceutical manufacturers use (S)-3-Aminopiperidine Dihydrochloride for custom synthesis of chiral antiviral APIs. The raw material participates in stereoselective amine incorporation during multi-step procedures to build core heterocyclic structures required in next-generation antiviral therapies. Control of enantiomeric purity is critical to avoid racemic byproduct formation, directly influencing API registration and pharmacological activity for regulated global markets.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
• USP/NF, EP, JP pharmacopoeial monographs for relevant APIs
• FDA 21 CFR Parts 210/211 (cGMP requirements)
• EMA QP Declaration standards for imported intermediates

Typical usage ratio

• Varies from 0.5 to 1.2 equivalents relative to the coupling partner, adjusted based on the target API structure and desired yield.

Downstream process integration

• Added to high-purity solvent under nitrogen before chiral amide or urea bond formation.
• Batchwise addition monitored by HPLC, integrating into Step 2 or 3 of multi-stage syntheses.
• Purification follows by crystallization, ensuring enantiomeric excess as specified by the final drug master file.

Final product types

• Chiral antiviral APIs for hepatitis and influenza therapies
• Intermediate building blocks for next-generation HIV integrase inhibitors
• Single-enantiomer nucleoside analogues
• Submission-quality API lots for clinical trials

2. CNS Drug Discovery: Piperidine-Based Neuroactive Compound Synthesis

Research and development units at pharmaceutical firms utilize (S)-3-Aminopiperidine Dihydrochloride to build piperidine-containing scaffolds found in CNS drug candidates. The material enables stereochemically defined amination workflows to access multiple analogues for early-stage neuropharmacology screening, with strict analytical documentation for lead compound development and subsequent preclinical batch production.

Industry compliance standards

• GLP (Good Laboratory Practice) for preclinical synthesis
• OECD Series on Principles of GLP
• USP General Chapter <825> for analytical method validation
• Controlled Substances Act (if intermediates regulated)

Typical usage ratio

• 0.8 - 1.5 molar equivalents, depending on substitution pattern of the piperidine core and diversity library scale.

Downstream process integration

• Subjected to N-protection or reductive amination as part of parallel synthesis protocols.
• Feeds directly into scaffold diversification by acylation or alkylation under inert conditions.
• Utilized in high-throughput format for screening batches, then scaled for hit-to-lead optimization.

Final product types

• Lead CNS drug candidate libraries (e.g., for antipsychotic or antidepressant programs)
• Preclinical batches of neuroactive piperidines for animal studies
• Reference standards for bioanalytical method development
• Investigational New Drug (IND) submission compounds

3. Agrochemical Intermediate Production: Chiral Plant Protection Agents

Agrochemical sectors apply (S)-3-Aminopiperidine Dihydrochloride as a core intermediate in the synthesis of chiral piperidine fragments essential for the production of new-generation plant protection agents. The enantiopure amine functionality provides the basis for constructing active ingredients with targeted biological activity and minimized environmental persistence, essential for registration with global regulatory authorities.

Industry compliance standards

• FAO/WHO Specification on Pesticide Technical Grade Material
• OECD Guidelines for the Testing of Chemicals (Section 2: Effects on Biotic Systems)
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) for chemicals in the EU
• ISO 17025 laboratory quality for batch certification

Typical usage ratio

• Used at 0.9 – 1.3 equivalents in condensation with acylating agents, ratio depending on the designed agrochemical’s structural requirements and desired impurity profile.

Downstream process integration

• Enters as C3-piperidine amine source for selective cross-coupling with halogenated or sulfonated intermediates.
• Integrated prior to final oxidation/hydrolysis in multi-step synthesis of active components.
• Isolated as technical intermediate for onward formulation into bulk plant protection products.

Final product types

• Chiral pesticide actives for cereal and fruit crop protection
• Enantiopure herbicide precursors
• Technical-grade fungicide intermediates
• Biologically targeted insecticide active components

4. Specialty Fine Chemicals: Advanced Polymer Modifier Synthesis

Producers of specialty polymers and coatings employ (S)-3-Aminopiperidine Dihydrochloride to manufacture high-performance polymer modifiers. The compound introduces defined chiral centers into polymer backbones or side chains, enabling unique property tuning for technical films, adhesives, and surface treatments. Batch traceability and impurity profiling ensure suitability for use in high-value engineering applications subject to customer-specific and sectoral compliance.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• ASTM D5296 for polymeric materials testing
• TSCA Inventory listing for US manufacturing
• RoHS Directive 2011/65/EU for electronic device applications

Typical usage ratio

• Common loading: 0.05 – 0.2 wt% for polymer backbone modification; higher (up to 2%) for surface-functionalized compositions as dictated by end-use application.

Downstream process integration

• Used in catalytic functionalization steps before extrusion or molding.
• Dissolved and copolymerized with acrylate or polyurethane monomers.
• Can be introduced during masterbatch compounding for specialty film or fiber production.

Final product types

• High-performance technical films with chiral functional groups
• Electronics-compatible adhesives and coatings
• Optical-grade polymers for precision devices
• Surface-active monomers for specialty laminates